Exigência - art. 36 da LPI
#6.1
08/11/2026
RPI 2901
Application data
Number
112019018401Type
Filing
Publication
PCT
EP2018055404 The INPI issued a technical office action on this application. If it is not answered in time, the application is abandoned (art. 36 of the Brazilian IP Act).
Deadline to answer the office action:11/09/2026(76 days left)
Latest action published by the INPI: 08/11/2026. We update with every new RPI gazette, published weekly.
Applicants
MERCK PATENT GMBH
DE
PFIZER, INC.
US
Inventors
A. R. (pessoa física)
IT
G. R. (pessoa física)
IT
M. S. (pessoa física)
IT
S. F. (pessoa física)
IT
IPC Classification
Priority claims
EP
17159354.4 · 03/06/2017
Abstract
A presente invenção refere-se a uma nova formulação de anticorpo anti-PD-L1. Em particular, a invenção refere-se a uma formulação farmacêutica aquosa do anticorpo anti-TP-L Avelumab.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.1
08/11/2026
RPI 2901
#6.1
06/09/2026
RPI 2892
#6.23
07/08/2025
RPI 2844
#15.35
10/19/2021
RPI 2650
#1.3
04/07/2020
RPI 2570
#1.1
09/17/2019
RPI 2541
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.